Marc A Pohl

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations
    Marc A Pohl
    Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A51, Cleveland, OH 44195, USA
    J Am Soc Nephrol 16:3027-37. 2005

Detail Information

Publications1

  1. ncbi Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations
    Marc A Pohl
    Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A51, Cleveland, OH 44195, USA
    J Am Soc Nephrol 16:3027-37. 2005
    ..There was no correlation between diastolic BP and renal outcomes. We recommend a SBP target between 120 and 130 mmHg, in conjunction with blockade of the renin-angiotensin system, in patients with type 2 diabetic nephropathy...